United States

Impel Pharmaceuticals is a biopharmaceutical company that develops and commercializes therapies for patients with central nervous system diseases in the US. Its lead product candidate is Trudhesa, an upper nasal formulation of dihydroergotamine for the acute treatment of migraine. The company is also developing INP105 and INP107, upper nasal formulations for the treatment of agitation and aggression in autism spectrum disorder and OFF episodes in Parkinson's disease, respectively. Impel Pharmaceuticals was incorporated in 2008 and is headquartered in Seattle, Washington.

Google

프로덕트 매니저

데이터 사이언티스트

Impel NeuroPharma

Impel NeuroPharma 공개 채용

경력을 한 단계 올릴 준비가 되셨나요? Impel NeuroPharma의 공개 직무를 확인해 보세요.